Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE
| Report ID | 7392 |
| Drug Identification Number | 02408090 |
| Brand name | MYLAN-BUPRENORPHINE/NALOXONE |
| Common or Proper name | BUPRENORPHINE/NALOXONE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BUPRENORPHINE NALOXONE |
| Strength(s) | 2MG 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | SUBLINGUAL |
| Packaging size | 100BT |
| ATC code | N07BC |
| ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-07-03 |
| Actual start date | 2018-06-26 |
| Estimated end date | Unknown |
| Actual end date | 2019-09-17 |
| Shortage status | Resolved |
| Updated date | 2019-09-18 |
| Company comments | discontinued in ID 94044. Last lot 3085355 exp 2019-05-31 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2017-04-20 | English | Compare |
| v2 | 2017-04-20 | French | Compare |
| v1 | 2017-04-20 | English | Compare |